| Type | Description |
|---|---|
| Definition | forkhead box C2 |
| Date | Results | Publications |
|---|---|---|
| 2021-04-17 13:11:00 | LncRNA FOXC2-AS1 enhances FOXC2 mRNA stability to promote colorectal cancer progression via activation of Ca(2+)-FAK signal pathway. | 32513911 |
| 2021-02-20 13:35:00 | FOXC2 Disease Mutations Identified in Lymphedema Distichiasis Patients Impair Transcriptional Activity and | 32698337 |
| 2021-02-13 13:30:00 | LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis. | 32271448 |
| 2020-11-21 13:21:00 | Functional polymorphisms in FOXC2 gene and Epithelial ovarian Cancer susceptibility in Chinese population. | 32222147 |
| 2020-07-25 11:35:00 | we have demonstrated that FOXC2 is strongly expressed in primary, metastatic and castration resistant prostate cancers, and is a strong predictor of outcome, of potential importance for prognostication and targeted therapy. | 31464093 |
| Type | IDs |
|---|---|
| Synonymous | FKHL14, LD, MFH-1, MFH1 |
| Gene |
UniProtKB-ID:
FOXC2_HUMAN
UniprotKB:
Q99958
UniParc:
UPI000012ADC6
EMBL:
BC113439,
BC113437,
Y08223,
GQ282998
Ensembl:
ENSG00000176692
KO:
hsa:2303
|
| Nucleutide sequences |
EMBL-CDS:
CAA69400.1,
ACS83751.1,
AAI13440.1,
AAI13438.1
Ensembl_TRS:
ENST00000649859
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000497759
RefSeq:
NP_005242.1
|
| Others |
UniRef100:
UniRef100_Q99958
UniRef90:
UniRef90_Q99958
UniRef50:
UniRef50_Q61850
UniGene:
Hs.436448
CCDS:
CCDS10958.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员